Not much news regarding the trials or status with FDA approvals, or partnerships.
Quarterly cash burn of nearly $32m, with only $77.5m on hand is a bit concerning. But as long as partnerships happen that should be ok.
I'm over simplifying and likely missing something, happy to be corrected!
Ann: Appendix 4C Quarterly Activity Report, page-4
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.070(5.02%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.473M | 3.788M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2570 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 11971 | 10 |
View Market Depth
| Last trade - 15.56pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |